Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: Apache Indian who wrote (411)	12/29/1998 11:25:00 PM
From: BRAVEHEART	Read Replies (1) \| Respond to of 1494

Do you think there are any Major Pharmas who feel left out of the $1 billion potential marketplace. I'd say there may be a few out there interested in partnering Memantine. Especially for the MERZ indications along with the Aids related Dementia trial NTI is running concurrently... For anyone attempting to arrive at the potential market size I'd say we just got our answer. biz.yahoo.com Too bad Nti doesn't get mentioned. The plague of being a small company. Wait till a major Pharma partners the product. That should get some attention. THE TRUTH IS OUT THERE LONE WOLF